MAIA Biotechnology, Inc. (MAIA) is a publicly traded Healthcare sector company. As of May 21, 2026, MAIA trades at $1.29 with a market cap of $76.61M and a P/E ratio of -1.82. MAIA moved +3.66% today. Year to date, MAIA is -14.57%; over the trailing twelve months it is -29.12%. Its 52-week range spans $0.87 to $3.48. Analyst consensus is buy with an average price target of $14.00. Rallies surfaces MAIA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading MAIA stock inside the company?
Recent MAIA insider activity includes Smith Stan bought 57.19K, CHAOUKI STEVEN M bought 40.85K, Louie Ngar Yee bought 81.70K, Smith Stan bought 4.58K, and Smith Stan bought 4.58K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
MAIA Key Metrics
Key financial metrics for MAIA
Metric
Value
Price
$1.29
Market Cap
$76.61M
P/E Ratio
-1.82
EPS
$-0.70
Dividend Yield
0.00%
52-Week High
$3.48
52-Week Low
$0.87
Volume
0
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-22.40M
Gross Margin
0.00%
Recent MAIA Insider Trades
Smith Stan bought 57.19K (~$70.00K) on Dec 22, 2025.
CHAOUKI STEVEN M bought 40.85K (~$50.00K) on Dec 22, 2025.
Louie Ngar Yee bought 81.70K (~$100.00K) on Dec 22, 2025.
Recent MAIA insider activity includes Smith Stan bought 57.19K, CHAOUKI STEVEN M bought 40.85K, Louie Ngar Yee bought 81.70K, Smith Stan bought 4.58K, and Smith Stan bought 4.58K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for MAIA?
Yes. Rallies tracks MAIA insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is MAIA research on Rallies investment advice?
No. Rallies provides research, data, and educational context for MAIA. It does not provide personalized investment advice.
